HK1122798A1 - 1- [2' , 3' -dideoxy-3' c- (hydroxymethyl) - beta-d-erythro-pentofuranosyl] cytosine derivatives as hiv inhibitors - Google Patents

1- [2' , 3' -dideoxy-3' c- (hydroxymethyl) - beta-d-erythro-pentofuranosyl] cytosine derivatives as hiv inhibitors

Info

Publication number
HK1122798A1
HK1122798A1 HK08113816.7A HK08113816A HK1122798A1 HK 1122798 A1 HK1122798 A1 HK 1122798A1 HK 08113816 A HK08113816 A HK 08113816A HK 1122798 A1 HK1122798 A1 HK 1122798A1
Authority
HK
Hong Kong
Prior art keywords
pentofuranosyl
erythro
dideoxy
hydroxymethyl
beta
Prior art date
Application number
HK08113816.7A
Other languages
English (en)
Inventor
Xiao-Xiong Zhou
Christer Sahlberg
Original Assignee
Medivir Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medivir Ab filed Critical Medivir Ab
Publication of HK1122798A1 publication Critical patent/HK1122798A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
HK08113816.7A 2005-07-07 2008-12-19 1- [2' , 3' -dideoxy-3' c- (hydroxymethyl) - beta-d-erythro-pentofuranosyl] cytosine derivatives as hiv inhibitors HK1122798A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0513835.9A GB0513835D0 (en) 2005-07-07 2005-07-07 HIV inhibitors
PCT/EP2006/063919 WO2007006707A1 (en) 2005-07-07 2006-07-05 1- [2' , 3' -dideoxy-3' c- (hydroxymethyl) - beta-d-erythro-pentofuranosyl] cytosine derivatives as hiv inhibitors

Publications (1)

Publication Number Publication Date
HK1122798A1 true HK1122798A1 (en) 2009-05-29

Family

ID=34856749

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08113816.7A HK1122798A1 (en) 2005-07-07 2008-12-19 1- [2' , 3' -dideoxy-3' c- (hydroxymethyl) - beta-d-erythro-pentofuranosyl] cytosine derivatives as hiv inhibitors

Country Status (19)

Country Link
US (2) US7888367B2 (xx)
EP (2) EP2336135A3 (xx)
JP (1) JP5174660B2 (xx)
CN (1) CN101213198B (xx)
AT (1) ATE527267T1 (xx)
AU (1) AU2006268743C1 (xx)
BR (1) BRPI0612678A2 (xx)
CA (1) CA2610210A1 (xx)
CY (1) CY1112164T1 (xx)
DK (1) DK1899352T3 (xx)
ES (1) ES2373743T3 (xx)
GB (1) GB0513835D0 (xx)
HK (1) HK1122798A1 (xx)
HR (1) HRP20110830T1 (xx)
MX (1) MX2008000221A (xx)
PL (1) PL1899352T3 (xx)
PT (1) PT1899352E (xx)
WO (1) WO2007006707A1 (xx)
ZA (1) ZA200710662B (xx)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8810907D0 (en) 1988-05-09 1988-06-15 British Telecomm Fluoride glass optical coupler & method of manufacture
ZA902631B (en) * 1989-04-06 1990-12-28 Bristol Myers Squibb Co 3'-substituted methyl nucleosides as antiviral agents
US5866775A (en) 1990-09-28 1999-02-02 Monsanto Company Glyphosate-tolerant 5-enolpyruvyl-3-phosphoshikimate synthases
US5627160A (en) * 1993-05-25 1997-05-06 Yale University L-2',3'-dideoxy nucleoside analogs as anti-hepatitis B (HBV) and anti-HIV agents
AU697612B2 (en) * 1994-05-31 1998-10-15 Medivir Ab Post exposure prevention of HIV
US5612319A (en) 1994-05-31 1997-03-18 Medivir Ab Postexposure prevention of HIV infection or seroconversion
ATE200900T1 (de) 1997-08-15 2001-05-15 Medivir Ab Analoge nukleoside, wie antivirale einschliesslich inhibitoren der retroviralen reverstranskriptase und der dna polymerase des hepatitis b virus
BR0110023A (pt) * 2000-04-13 2003-12-30 Pharmasset Ltd Derivados de nucleosìdeo 3'-ou-2' substituìdos para tratamento de infecções por vìrus da hepatite
US7109931B2 (en) 2004-06-18 2006-09-19 Centurion Wireless Technologies, Inc. Method and apparatus to control an antenna efficiency test device
WO2006070004A1 (en) * 2004-12-30 2006-07-06 Medivir Ab Compounds useful in the treatment of hiv

Also Published As

Publication number Publication date
CY1112164T1 (el) 2015-12-09
CA2610210A1 (en) 2007-01-18
CN101213198B (zh) 2011-08-03
GB0513835D0 (en) 2005-08-10
HRP20110830T1 (hr) 2011-12-31
EP1899352B1 (en) 2011-10-05
US20110112294A1 (en) 2011-05-12
WO2007006707A1 (en) 2007-01-18
PL1899352T3 (pl) 2012-03-30
AU2006268743B2 (en) 2010-07-29
JP5174660B2 (ja) 2013-04-03
JP2008545002A (ja) 2008-12-11
ZA200710662B (en) 2008-11-26
US8143396B2 (en) 2012-03-27
EP2336135A2 (en) 2011-06-22
US7888367B2 (en) 2011-02-15
AU2006268743A1 (en) 2007-01-18
CN101213198A (zh) 2008-07-02
EP2336135A3 (en) 2011-07-27
BRPI0612678A2 (pt) 2010-11-30
EP1899352A1 (en) 2008-03-19
PT1899352E (pt) 2012-01-05
ES2373743T3 (es) 2012-02-08
AU2006268743C1 (en) 2010-12-16
US20080221140A1 (en) 2008-09-11
ATE527267T1 (de) 2011-10-15
MX2008000221A (es) 2008-03-18
DK1899352T3 (da) 2012-01-30

Similar Documents

Publication Publication Date Title
DE60210944D1 (de) N-substituierte heterocyclische nichtaryl-nmda/nr2b-antagonisten
TW200728276A (en) Oxindole derivatives
ATE397605T1 (de) Nebivolol und dessen pharmazeutisch unbedenkliche salze, herstellungsverfahren und pharmazeutische zusammensetzungen von nebivolol
TW200730494A (en) Novel compounds
GEP20094736B (en) Prodrugs of piperazine and substituted piperidine antiviral agents
UA84712C2 (xx) N-заміщені піразоліламідилбензімідазоліли як c-kit інгібітори$n-замещенные пиразолиламидилбензимидазолилы как c-kit ингибиторы
EA200801083A1 (ru) Новые производные дигидропсевдоэритромицина
DE602006011752D1 (de) Als antikoagulationsmittel geeignete phenylglycinamid- und pyridylglycinamidderivate
UY30310A1 (es) Derivados 2-azetidinona, sales, solvatos, composiciones farmacéuticas conteniéndolos, procesos de preparacion y aplicaciones
TW200502230A (en) Dual nk1/nk3 derivatives
MY148538A (en) Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions
WO2005021544A3 (en) N3-substituted imidazopyridine-derivatives as c-kit inhibitors
TW200639156A (en) New compounds
GB0710121D0 (en) Antifungal agents
IL169184A0 (en) Aromatic compounds as anti-inflammatory, immunomdulatory and anti-proliferatory agents
MXPA05013474A (es) Derivados de quinolilamida como antagonistas de ccr-5.
CY1110130T1 (el) Παραγωγα μορφολινης για χρηση ως αγωνιστες ντοπαμινης στην θεραπευτικη αγωγη σεξουαλικης δυσλειτουργιας i.α.
TW200716571A (en) Heterocyclic reverse transcriptase inhibitors
MXPA04006041A (es) Antivirales de piridoquinoxalina.
ATE488510T1 (de) Heterocyclische derivate, deren herstellung und therapeutische verwendung
DE60231426D1 (de) Solubilisierte topoisomerase-gift-mittel
PT2366393E (pt) Roflumilaste para o tratamento da hipertensão pulmonar
EP2183256A4 (en) THERAPEUTIC COMPOUNDS
BR0200536A (pt) Compostos de sulfonilpiridazinana úteis como inibidores de aldose reductase
EP1987834A3 (en) Substituted piperidines as therapeutic compounds

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)